LATE-BREAKING ABSTRACT: RESPIRE 1: Ciprofloxacin DPI 32.5mg b.d. administered 14 day on/off or 28 day on/offvsplacebo for 48 weeks in subjects with non-cystic fibrosis bronchiectasis (NCFB) | Publicación